PharmaJet welcomes Marian Wentworth to its Board of Directors

– USA, CO –  PharmaJet, the maker of innovative, needle-free injection technology, today announced the appointment of Marian Wentworth to its Board of Directors.

Ms. Wentworth, President and CEO of Management Sciences for Health, is an accomplished global health executive with extensive experience in global strategy, innovation, and development.

“We are very pleased to welcome Ms. Wentworth to the PharmaJet Board of Directors. Her global health experience with NGO’s and senior management experience at Merck, combined with her strategic vision and operations expertise will be a valuable addition to our board.” said Executive Chairman, Ron Lowy.

About Marian Wentworth

Since 2017, Ms. Wentworth has been President and CEO of Management Sciences for Health, a nonprofit organization that works with low- and middle-income markets across 30 countries to strengthen their health systems. In that role, she manages a team of 1200 professionals working on a national, district, and local level to deliver health products and services from business management to pharmacy, labs, and clinical care.

Previously, Ms. Wentworth held executive roles at Merck & Co., most recently as VP, Global Vaccines Strategy and Innovation, where she was responsible for the $6 billion global vaccines business. During her tenure at Merck, she also held executive commercial strategy and operations roles for several vaccines including Varicella, Zostavax, Afluria, and Gardasil to name a few.

Ms. Wentworth commented, “I look forward to joining PharmaJet’s Board of Directors during this critical time for vaccine development and execution, and using my broad vaccine operational and development expertise to accelerate the adoption of PharmaJet’s needle-free solution.”

Ms. Wentworth is Chair of the Board of Medsource, a privately held group purchasing organization in Kenya. She holds a Bachelor of Arts degree in Mathematics from Harvard University.

About PharmaJet

PharmaJet’s mission is worldwide acceptance of PharmaJet Needle-free Injection Systems as a standard of care in the vaccine delivery market. The PharmaJet Needle-free Systems are safe, fast, and easy-to-use. They eliminate needlestick injuries, needle reuse, and cross-contamination, and help reduce sharps waste disposal. The Stratis System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis System has CE Mark and WHO PQS certification for intradermal injections.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.